Delta variant is 'Covid-19 on steroids,' says experts


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
More update on Delta variant

Twenty-four states have seen an uptick of at least 10% in Covid-19 cases over the past week, Johns Hopkins University data shows, as health experts and the federal government keep pressing for more people to get vaccinated.

The rapid spread of the Delta variant of the coronavirus has only ratcheted up the pressure.

That variant, first identified in India, accounted for 51.7% of all new Covid-19 infections in the country over the two weeks that ended Saturday, the US Centers for Disease Control and Prevention has estimated.

"We should think about the Delta variant as the 2020 version of Covid-19 on steroids," Andy Slavitt, a former senior adviser to Joe Biden's Covid Response Team, told CNN on Wednesday. "It's twice as infectious. Fortunately, unlike 2020, we actually have a tool that stops the Delta variant in its tracks: It's called  vaccine."

For fully vaccinated people, the variant "presents very little threat to you, very unlikely that you're gonna get sick," he said
Full approval for vaccines from the US Food and Drug Administration could encourage more people to get vaccinated, Slavitt and other experts have said. The current vaccines distributed in the US are authorized for emergency use only. Full approval for the Pfizer vaccine could come as early as this month, Slavitt said Tuesday.

On Thursday, Pfizer said it was seeing waning immunity from its vaccine. The company is now picking up its efforts to develop a booster dose that will protect people from variants.

"Based on the totality of the data they have to date, Pfizer and BioNTech believe that a third dose may be beneficial within 6 to 12 months following the second dose to maintain the highest levels of protection," the company said in a statement emailed to CNN.

The company said booster doses of its vaccine, developed with BioNTech, produce levels of neutralizing antibodies that are five to 10 times higher than what's produced after two doses. And it added that it's also developing a new formulation for a booster dose that may protect people from new variants more thoroughly.
A Pfizer spokesperson later told CNN the company planned to file for emergency use authorization for a booster dose with the FDA in August.

Tags : #DeltaVariant #Coronavirus #Steroids #CDC #Pfizer #BoosterDose #JohnsHopkinsUniversity

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026